These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9629521)
1. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Davidsson P; Blennow K Int Psychogeriatr; 1998 Mar; 10(1):11-23. PubMed ID: 9629521 [TBL] [Abstract][Full Text] [Related]
2. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505 [TBL] [Abstract][Full Text] [Related]
3. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. Reddy PH; Mani G; Park BS; Jacques J; Murdoch G; Whetsell W; Kaye J; Manczak M J Alzheimers Dis; 2005 Apr; 7(2):103-17; discussion 173-80. PubMed ID: 15851848 [TBL] [Abstract][Full Text] [Related]
4. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Masliah E; Hansen L; Albright T; Mallory M; Terry RD Acta Neuropathol; 1991; 81(4):428-33. PubMed ID: 1903014 [TBL] [Abstract][Full Text] [Related]
6. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253 [TBL] [Abstract][Full Text] [Related]
7. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603 [TBL] [Abstract][Full Text] [Related]
8. Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study. Baloyannis SJ; Manolidis SL; Manolidis LS Acta Otolaryngol; 2000 Mar; 120(2):247-50. PubMed ID: 11603783 [TBL] [Abstract][Full Text] [Related]
9. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Lovell MA; Smith JL; Xiong S; Markesbery WR Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263 [TBL] [Abstract][Full Text] [Related]
10. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186 [TBL] [Abstract][Full Text] [Related]
11. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. Sze CI; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ J Neurol Sci; 2000 Apr; 175(2):81-90. PubMed ID: 10831767 [TBL] [Abstract][Full Text] [Related]
12. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? Davidsson P; Jahn R; Bergquist J; Ekman R; Blennow K Mol Chem Neuropathol; 1996 Feb; 27(2):195-210. PubMed ID: 8962603 [TBL] [Abstract][Full Text] [Related]
13. Synaptic pathology of Alzheimer's disease. Lassmann H; Fischer P; Jellinger K Ann N Y Acad Sci; 1993 Sep; 695():59-64. PubMed ID: 8239314 [TBL] [Abstract][Full Text] [Related]
14. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. Minger SL; Honer WG; Esiri MM; McDonald B; Keene J; Nicoll JA; Carter J; Hope T; Francis PT J Neuropathol Exp Neurol; 2001 Oct; 60(10):929-36. PubMed ID: 11589423 [TBL] [Abstract][Full Text] [Related]
15. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. Harigaya Y; Shoji M; Shirao T; Hirai S J Neurosci Res; 1996 Jan; 43(1):87-92. PubMed ID: 8838578 [TBL] [Abstract][Full Text] [Related]
17. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842 [TBL] [Abstract][Full Text] [Related]
18. Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease. Tiwari SS; d'Orange M; Troakes C; Shurovi BN; Engmann O; Noble W; Hortobágyi T; Giese KP Mol Brain; 2015 Jan; 8():6. PubMed ID: 25631211 [TBL] [Abstract][Full Text] [Related]
19. Distribution of synaptic vesicle proteins in the mammalian retina identifies obligatory and facultative components of ribbon synapses. Von Kriegstein K; Schmitz F; Link E; Südhof TC Eur J Neurosci; 1999 Apr; 11(4):1335-48. PubMed ID: 10103129 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]